YS Biopharma to Participate in Citi's 18th Annual Biopharma Conference
- Written by PR Newswire
![]() |
GAITHERSBURG, Md., Sept. 5, 2023 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced that it will...
Read more: YS Biopharma to Participate in Citi's 18th Annual Biopharma Conference